Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.
Melikoglu MA, Ataman S, Bodur H, Cay HF, Capkin E, Akgul O, Cevik R, Gogus F, Kamanli A, Yurdakul FG, Gurer G, Yagci I, Rezvani A, Duruoz MT, Sunar I. Melikoglu MA, et al. Among authors: gogus f. Rheumatol Int. 2021 Nov;41(11):1971-1978. doi: 10.1007/s00296-021-04992-3. Epub 2021 Sep 24. Rheumatol Int. 2021. PMID: 34559275
The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey.
Malhan S, Pay S, Ataman S, Dalkilic E, Dinc A, Erken E, Ertenli I, Ertugrul E, Gogus F, Hamuryudan V, Inanc M, Karaarslan Y, Karadag O, Karakoc Y, Keskin G, Kisacik B, Kiraz S, Oksel F, Oksuz E, Pirildar T, Sari I, Soy M, Senturk T, Taylan A. Malhan S, et al. Among authors: gogus f. Clin Exp Rheumatol. 2012 Mar-Apr;30(2):202-7. Epub 2012 Apr 13. Clin Exp Rheumatol. 2012. PMID: 22546069
Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions.
Nas K, Kiliç E, Çevik R, Bodur H, Ataman Ş, Ayhan F, Akgül Ö, Akinci A, Altay Z, Çapkın E, Dağli AZ, Duruöz T, Gürer G, Göğüş F, Garip Y, Kaçar C, Kamanli A, Kaptanoğlu E, Kaya T, Kocabaş H, Özdemirel EA, Özel S, Sezer İ, Sunar İ, Yilmaz G. Nas K, et al. Among authors: gogus f. Arch Rheumatol. 2018 May 21;33(2):108-127. doi: 10.5606/ArchRheumatol.2018.6946. eCollection 2018 Jun. Arch Rheumatol. 2018. PMID: 30207576 Free PMC article.
Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry.
Akgul O, Bodur H, Ataman S, Yurdakul FG, Capkin E, Gurer G, Sezer I, Duruoz MT, Melikoglu MA, Cay HF, Rezvani A, Yagci I, Gogus F, Kamanli A, Cevik R. Akgul O, et al. Among authors: gogus f. Rheumatol Int. 2020 Nov;40(11):1793-1801. doi: 10.1007/s00296-020-04680-8. Epub 2020 Aug 19. Rheumatol Int. 2020. PMID: 32814986
Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis.
Ataman S, Sunar I, Bodur H, Melikoglu MA, Cay HF, Capkin E, Akgul O, Cevik R, Gogus F, Kamanli A, Yurdakul FG, Gurer G, Yagci I, Rezvani A, Duruoz MT. Ataman S, et al. Among authors: gogus f. Rheumatol Ther. 2022 Feb;9(1):223-241. doi: 10.1007/s40744-021-00403-y. Epub 2021 Dec 1. Rheumatol Ther. 2022. PMID: 34850376 Free PMC article.
Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.
Bodur H, Yurdakul FG, Ataman S, Cay HF, Gurer G, Capkin E, Sezer İ, Duruoz MT, Melikoglu MA, Rezvani A, Yagci I, Gogus F, Kamanli A, Akgul O, Cevik R. Bodur H, et al. Among authors: gogus f. Clin Rheumatol. 2022 Jul;41(7):2053-2063. doi: 10.1007/s10067-022-06145-8. Epub 2022 Mar 30. Clin Rheumatol. 2022. PMID: 35353263
113 results